Mubadala Health incorporates continuous care model for medical grade remote monitoring

Mubadala Health, the integrated healthcare network of Mubadala Investment Company, has announced a strategic collaboration with BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, to incorporate BioIntelliSense’s innovative remote care technologies with Mubadala Health’s continuous care model to drive clinical workflow efficiencies, unlock data-driven clinical insights and deliver a personalized care experience.

Hasan Jasem Al Nowais, Chief Executive Officer of Mubadala Health, said,

"This partnership is in line with our comprehensive strategy to provide innovative care to our patients and create efficiencies in the way healthcare is delivered. Through the use of this new technology, Mubadala Health can better meet the needs of patients, delivering customised care, at the right time and place, across our integrated network. BioIntelliSense’s technology will allow our clinicians to access near real-time information on patients’ vital signs and symptoms, enabling them to identify changes in health sooner and intervene earlier."

"This strategic partnership will help create fully integrated, continuous care delivery that starts during a patient’s hospitalisation, enabling monitoring of their health status throughout their recovery process, and from the comfort of their own home after leaving the hospital," Al Nowais added.

James Mault, MD, Founder and Chief Executive Officer of BioIntelliSense said,

"The collaboration with Mubadala Health in launching a continuous remote monitoring capability will help providers deliver a new level of care to patients in UAE,"

"This partnership with Mubadala Health represents a tremendous opportunity to apply the BioSticker and BioButton wearable medical devices across multiple care settings, make early detection simple, and empower care teams with personalised clinical intelligence that enables informed proactive interventions."

The adoption of BioIntelliSense's flagship FDA-cleared BioSticker and medical grade BioButton wearable devices, along with its algorithmic-based data services, enables Mubadala Health to capture continuous multi-parameter patient trending data passively and securely across a broad range of physiological leading indicators (resting heart rate, respiratory rate, temperature, body position, activity level, sleep, gait analysis, et al.).

Together with BioCloud analytics and intelligent alerting, Mubadala Health can remotely monitor at-risk, long-term care patient populations by exception and allocate resources efficiently based on a documented clinical need through a centralised command centre using the data from the BioIntelliSense multi-parameter wearable devices.

News Source: Emirates News Agency